Cite
Nyquist MD, Ang LS, Corella A, et al. Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth. J Clin Invest. 2021;131(12)doi: 10.1172/JCI151719.
Nyquist, M. D., Ang, L. S., Corella, A., Coleman, I. M., Meers, M. P., Christiani, A. J., Pierce, C., Janssens, D. H., Meade, H. E., Bose, A., Brady, L., Howard, T., De Sarkar, N., Frank, S. B., Dumpit, R. F., Dalton, J. T., Corey, E., Plymate, S. R., Haffner, M. C., Mostaghel, E. A., & Nelson, P. S. (2021). Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth. The Journal of clinical investigation, 131(12), . https://doi.org/10.1172/JCI151719
Nyquist, Michael D, et al. "Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth." The Journal of clinical investigation vol. 131,12 (2021). doi: https://doi.org/10.1172/JCI151719
Nyquist MD, Ang LS, Corella A, Coleman IM, Meers MP, Christiani AJ, Pierce C, Janssens DH, Meade HE, Bose A, Brady L, Howard T, De Sarkar N, Frank SB, Dumpit RF, Dalton JT, Corey E, Plymate SR, Haffner MC, Mostaghel EA, Nelson PS. Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth. J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI151719. PMID: 34128479; PMCID: PMC8203444.
Copy
Download .nbib
